Epigenetic and genetic alterations in non-small cell lung cancer
- Prosjektnummer
- SFP1032-12
- Ansvarlig person
- Lill-Tove Busund
- Institusjon
- UiT Norges arktiske universitet
- Prosjektkategori
- Postdoktorstipend
- Helsekategori
- Cancer and neoplasms
- Forskningsaktivitet
- 2. Aetiology, 5. Treatment Development
Alle medlemmer i gruppen har i alle trinn kommet med kritisk vurdering ved valg av prognostiske markører og evaluering av resultater. Selv ved planlegging av publisering kunne man få en felles vurdering av resultatene og planlegge vinkling ved publisering av resultater.
Progesterone Receptors in Prostate Cancer: Progesterone receptor B is the isoform associated with disease progression.
Sci Rep 2018 Jul 27;8(1):11358. Epub 2018 jul 27
PMID: 30054508
Evaluation of tumor-infiltrating lymphocytes using routine H&E slides predicts patient survival in resected non-small cell lung cancer.
Hum Pathol 2018 Sep;79():188-198. Epub 2018 jun 6
PMID: 29885403
A gender specific improved survival related to stromal miR-143 and miR-145 expression in non-small cell lung cancer.
Sci Rep 2018 Jun 04;8(1):8549. Epub 2018 jun 4
PMID: 29867125
Transcription factor PAX6 as a novel prognostic factor and putative tumour suppressor in non-small cell lung cancer.
Sci Rep 2018 Mar 22;8(1):5059. Epub 2018 mar 22
PMID: 29568088
LAG-3 in Non-Small-cell Lung Cancer: Expression in Primary Tumors and Metastatic Lymph Nodes Is Associated With Improved Survival.
Clin Lung Cancer 2018 05;19(3):249-259.e2. Epub 2017 des 11
PMID: 29396238
Corrigendum to "Prognostic relevance of estrogen receptor α, β and aromatase expression in non-small cell lung cancer" [Steroids 113 (2016) 5-13].
Steroids 2018 02;130():36-37. Epub 2017 des 19
PMID: 29273210
The impact of MET, IGF-1, IGF1R expression and EGFR mutations on survival of patients with non-small-cell lung cancer.
PLoS One 2017;12(7):e0181527. Epub 2017 jul 25
PMID: 28742836
Assessing PDL-1 and PD-1 in Non-Small Cell Lung Cancer: A Novel Immunoscore Approach.
Clin Lung Cancer 2017 Mar;18(2):220-233.e8. Epub 2016 okt 5
PMID: 27816392
The presence of intraepithelial CD45RO+ cells in resected lymph nodes with metastases from NSCLC patients is an independent predictor of disease-specific survival.
Br J Cancer 2016 May 10;114(10):1145-51. Epub 2016 apr 7
PMID: 27167450
Prognostic relevance of estrogen receptor a, ß and aromatase expression in non-small cell lung cancer.
Steroids 2016 Sep;113():5-13. Epub 2016 mai 24
PMID: 27234503
Estrogen receptors a and ß and aromatase as independent predictors for prostate cancer outcome.
Sci Rep 2016 Sep 09;6():33114. Epub 2016 sep 9
PMID: 27610593
Prognostic effect of intratumoral neutrophils across histological subtypes of non-small cell lung cancer.
Oncotarget 2016 Nov 01;7(44):72184-72196.
PMID: 27708229
Erratum to: Prognostic impact of CXCL16 and CXCR6 in non-small cell lung cancer: combined high CXCL16 expression in tumor stroma and cancer cells yields improved survival.
BMC Cancer 2016 Nov 24;16(1):916. Epub 2016 nov 24
PMID: 27884136
The prognostic role of progesterone receptor expression in non-small cell lung cancer patients: Gender-related impacts and correlation with disease-specific survival.
Steroids 2015 Jun;98():29-36. Epub 2015 feb 7
PMID: 25668612
Stromal CD8+ T-cell Density—A Promising Supplement to TNM Staging in Non-Small Cell Lung Cancer.
Clin Cancer Res 2015 Jun 1;21(11):2635-43. Epub 2015 feb 13
PMID: 25680376
High progesterone receptor expression in prostate cancer is associated with clinical failure.
PLoS One 2015;10(2):e0116691. Epub 2015 feb 27
PMID: 25723513
Prognostic impact of CXCL16 and CXCR6 in non-small cell lung cancer: combined high CXCL16 expression in tumor stroma and cancer cells yields improved survival.
BMC Cancer 2015;15():441. Epub 2015 mai 29
PMID: 26021984
Cancer-associated fibroblasts from lung tumors maintain their immunosuppressive abilities after high-dose irradiation.
Front Oncol 2015;5():87. Epub 2015 mai 12
PMID: 26029659
Keratin 34betaE12/keratin7 expression is a prognostic factor of cancer-specific and overall survival in patients with early stage non-small cell lung cancer.
Acta Oncol 2016;55(2):167-77. Epub 2015 jun 9
PMID: 26057535
Cancer Associated Fibroblasts in Stage I-IIIA NSCLC: Prognostic Impact and Their Correlations with Tumor Molecular Markers.
PLoS One 2015;10(8):e0134965. Epub 2015 aug 7
PMID: 26252379
Stromal expression of VEGF-A and VEGFR-2 in prostate tissue is associated with biochemical and clinical recurrence after radical prostatectomy.
Prostate 2015 Nov;75(15):1682-93. Epub 2015 aug 13
PMID: 26268996
The prognostic significance of CXCL16 and its receptor C-X-C chemokine receptor 6 in prostate cancer.
Am J Pathol 2015 Oct;185(10):2722-30. Epub 2015 aug 10
PMID: 26272362
Strategies for clinical implementation of TNM-Immunoscore in resected nonsmall-cell lung cancer.
Ann Oncol 2016 Feb;27(2):225-32. Epub 2015 nov 16
PMID: 26578726
CD45RO(+) Memory T Lymphocytes - a Candidate Marker for TNM-Immunoscore in Squamous Non-Small Cell Lung Cancer.
Neoplasia 2015 Nov;17(11):839-48.
PMID: 26678911
Stromal expression of MiR-21 predicts biochemical failure in prostate cancer patients with Gleason score 6.
PLoS One 2014;9(11):e113039. Epub 2014 nov 17
PMID: 25401698
Infiltration of CD8+ lymphocytes is an independent prognostic factor of biochemical failure-free survival in prostate cancer.
Prostate 2014 Oct;74(14):1452-61. Epub 2014 aug 11
PMID: 25111810
Monocarboxylate transporters 1-4 in NSCLC: MCT1 is an independent prognostic marker for survival.
PLoS One 2014;9(9):e105038. Epub 2014 sep 16
PMID: 25225794
Stage and tissue-specific prognostic impact of miR-182 in NSCLC.
BMC Cancer 2014;14():138. Epub 2014 feb 27
PMID: 24575749
High tumor cell expression of microRNA-21 in node positive non-small cell lung cancer predicts a favorable clinical outcome.
BMC Clin Pathol 2014;14(1):9. Epub 2014 feb 13
PMID: 24524655
Positive prognostic impact of miR-210 in non-small cell lung cancer.
Lung Cancer 2014 Feb;83(2):272-8. Epub 2013 nov 14
PMID: 24305009
CD4/CD8 co-expression shows independent prognostic impact in resected non-small cell lung cancer patients treated with adjuvant radiotherapy.
Lung Cancer 2013 May;80(2):209-15. Epub 2013 feb 4
PMID: 23384671
MicroRNA signatures in tumor tissue related to angiogenesis in non-small cell lung cancer.
PLoS One 2012;7(1):e29671. Epub 2012 jan 25
PMID: 22295063
Overexpression of matrix metalloproteinase-7 and -9 in NSCLC tumor and stromal cells: correlation with a favorable clinical outcome.
Lung Cancer 2012 Feb;75(2):235-41. Epub 2011 jul 18
PMID: 21764478
CD4/CD8 Co-expression shows independent prognostic impact in resected non-small cell lung cancer in patients treated with adjuva
is accepted for publication in Lung Cancer
The prevalence and prognostic significance of endocrinology-related biomarkers in non-small cell lung cancer
- Disputert:
- juni 2018
- Hovedveileder:
- Samer Al-Saad
- Lill-Tove Busund Prosjektleder
- Samer Al-Saad Postdoktorstipendiat
- Tom Dønnem Prosjektdeltaker
- Roy M. Bremnes Prosjektdeltaker
- Mehrdad Rakaee Prosjektdeltaker
eRapport er utarbeidet av Sølvi Lerfald og Reidar Thorstensen, Regionalt kompetansesenter for klinisk forskning, Helse Vest RHF, og videreutvikles av de fire RHF-ene i fellesskap, med støtte fra Helse Vest IKT
Alle henvendelser rettes til eRapport, Helse Nord